Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0001415889-24-010827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-15 | 2024-04-11 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +14.0K | 14.0K | New | +$34.7K |
| DM | 2024-04-15 | 2024-04-11 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.73 | -14.0K | 0 | -100% | -$346.2K |
| D | 2024-04-15 | 2024-04-11 | ELVN | Hohl Benjamin | CFO | M - OptEx | $0.00 | -14.0K | 225.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-11 | M | A | 14,000 | $2.48 | 14,000 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-11 | S | D | 3,777 | $23.88 | 10,223 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $23.65 to $24.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Common Stock | 2024-04-11 | S | D | 10,223 | $25.04 | 0 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $24.69 to $25.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Derivative | Stock Option (right to buy) | 2024-04-11 | M | D | 14,000 | $0.00 | 225,370 | D | $2.48 · — to 2031-08-02 | 14,000 Common Stock | (F4) The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. |